RGAHX | UIVQX | RGAHX / UIVQX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 9 years | 3 years | - |
Gain YTD | 15.702 | 7.616 | 206% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 270B | 4.84M | 5,584,281% |
Annual Yield % from dividends | 0.64 | 0.51 | 127% |
Returns for 1 year | 18.54 | 16.70 | 111% |
Returns for 3 years | -7.05 | N/A | - |
Returns for 5 years | 46.96 | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DRYQX | 18.40 | 0.07 | +0.38% |
BNY Mellon Research Growth Y | |||
CGOLX | 20.85 | 0.06 | +0.29% |
Columbia International Div Inc Adv | |||
NYVBX | 20.72 | -0.13 | -0.62% |
Davis NY Venture B | |||
JIVAX | 31.46 | -0.27 | -0.85% |
JPMorgan U.S. Applied Data Sci Val A | |||
FTMSX | 23.69 | -0.26 | -1.09% |
FullerThaler Behvrl Mcr-Cp Eq Instl |